Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-23

Clinical Trial Update: Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of exenatide in patients with Type 2 Diabetes Mellitus using metformin or sulfonylureas with metformin; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)
  • Sulfonylurea (class)
  • metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED